Immune recall enhances cross-reactive antibody longevity after a large wave of SARS-CoV-2 breakthrough infection.

IF 40.8 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Signal Transduction and Targeted Therapy Pub Date : 2024-08-21 DOI:10.1038/s41392-024-01926-w

Dan Li, Qingfei Chu, Kang Li, Lanjuan Li, Yiming Shao

引用次数: 0

Abstract Image

查看原文本刊更多论文

大规模 SARS-CoV-2 突发性感染后，免疫召回会延长交叉反应抗体的寿命。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Signal Transduction and Targeted Therapy Biochemistry, Genetics and Molecular Biology-Genetics

CiteScore

44.50

自引率

1.50%

发文量

384

审稿时长

5 weeks

期刊介绍： Signal Transduction and Targeted Therapy is an open access journal that focuses on timely publication of cutting-edge discoveries and advancements in basic science and clinical research related to signal transduction and targeted therapy. Scope: The journal covers research on major human diseases, including, but not limited to: Cancer,Cardiovascular diseases,Autoimmune diseases,Nervous system diseases.